nedaplatin has been researched along with Cancer of Head in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 14 (40.00) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshi, A; Kobayashi, H; Kurihara, T; Momo, K; Sasaki, T; Shimane, T | 1 |
| Ohashi, T; Ohnishi, M; Okuda, H; Takada, N; Takagi, C; Takahashi, H | 1 |
| Furutani, K; Goto, Y; Hanai, N; Hasegawa, Y; Hirakawa, H; Ito, J; Kodaira, T; Ozawa, T; Suzuki, H; Tachibana, H; Tomita, N | 1 |
| Doi, K; Fujisaka, Y; Hayashi, H; Kawakami, H; Nakagawa, K; Nishimura, Y; Nishina, S; Okamoto, I; Okamoto, K; Satoh, T; Takeda, M; Tanaka, K; Terao, K; Ueda, S | 1 |
| Kogashiwa, Y; Kohno, N; Sato, D; Tsukahara, K; Yamauchi, K | 1 |
| Akiyama, K; Hoshikawa, H; Inamoto, R; Indo, K; Kishino, T; Miyashita, T; Mori, N; Mori, T | 1 |
| Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Nakamaru, Y; Onimaru, R; Sakashita, T; Shirato, H; Terasaka, S; Tsuchiya, K; Yasuda, K; Yoshida, D | 1 |
| Iwabuchi, H; Komatsu, S; Nakayama, S; Onizawa, K; Souma, T; Uchiyama, K; Yamada, M; Yasui, T | 1 |
| Araki, R; Itoh, A; Iwamizu, H; Kataoka, T; Kawarada, Y; Kumakura, Y; Miyazaki, M; Nagai, T; Ota, A; Yamada, K | 1 |
| Enomoto, T; Enomoto, Y; Kitano, H; Morizane, R; Nakahara, K; Nosaka, A; Sakoda, T | 1 |
| Egawa, S; Furuya, A; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H | 1 |
| Karaho, T; Kogashiwa, Y; Kohno, N; Maruyama, T; Matsuda, T; Nagafuji, H; Tsubosaka, T; Yamauchi, K | 1 |
| Murai, M; Ohashi, T; Ohnishi, M; Tanahashi, S | 1 |
| Iwabuchi, H; Nakayama, S; Sugiyama, K; Uchiyama, K; Yamada, M | 1 |
| Furutani, K; Fuwa, N; Ito, Y; Kamata, M; Kodaira, T; Matsumoto, A; Tachibana, H | 1 |
| Dake, Y; Enomoto, T; Ikeda, H; Kawano, A; Kitano, H; Saitoh, Y; Sakoda, T; Seno, S | 1 |
| Furukawa, M; Kawano, T; Komatsu, M; Kubota, A | 1 |
| Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Nakamori, S; Sawamura, T; Tsujinaka, T; Yamashita, S | 1 |
| Fujii, M | 1 |
| Asano, R; Iida, M; Kadokura, Y; Katsuno, M; Kobayashi, S; Kubota, H; Morimoto, M; Sanbe, T; Tachibana, S; Takemura, H | 1 |
| Furukawa, M; Hanamura, H; Komatsu, M; Kubota, A; Sugiyama, M | 1 |
| Feng, FY; Gao, YJ; Guan, XQ; Hu, Y; Li, CW; Liu, JW; Nan, KJ; Suo, AL; Wang, XW; Wu, LY; Zhang, MH; Zhang, P; Zhang, WD; Zhang, Y; Zhao, JB | 1 |
| Iwabuchi, H; Nakayama, S; Uchiyama, K | 1 |
| Daimon, T; Furutani, K; Fuwa, N; Kodaira, T; Nakamura, T; Tachibana, H | 1 |
| Daimon, T; Fuwa, N; Kodaira, T; Nakamura, T; Tachibana, H | 1 |
| Fukuda, S; Inuyama, Y; Satoh, N | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Kanzaki, J; Ohno, Y; Tokumaru, Y | 1 |
| Hojo, K; Kasai, H; Maekawa, R; Nishida, K; Sugita, K; Takeda, Y; Uchida, N; Wada, T; Yoshioka, T | 1 |
| Khattab, J; Urba, SG | 1 |
| Arai, Y; Enomoto, H; Kawai, S; Mikami, Y; Mochimatsu, I; Nagahara, T; Tsukuda, M; Yamaoka, H | 1 |
| Fuwa, N | 1 |
| Horiuchi, M; Miyake, H; Ota, K | 1 |
| Hayasaki, K; Horiuchi, M; Inuyama, Y; Komiyama, S; Miyake, H; Ota, K | 2 |
| Kubota, A; Ono, T; Sawaki, S; Takahashi, K; Tsukuda, M; Watanabe, S; Yanoma, S; Yoshida, T | 1 |
3 review(s) available for nedaplatin and Cancer of Head
| Article | Year |
|---|---|
[Head and neck cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Taxoids | 1997 |
Chemotherapy in head and neck cancer. Overview of newer agents.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids; Topotecan; Vinblastine; Vinorelbine | 1999 |
[Current and future state of chemoradiotherapy for head and neck cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Organoplatinum Compounds; Paclitaxel; Taxoids | 2002 |
15 trial(s) available for nedaplatin and Cancer of Head
| Article | Year |
|---|---|
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2013 |
Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Treatment Outcome | 2013 |
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Organoplatinum Compounds; Oxonic Acid; Squamous Cell Carcinoma of Head and Neck; Tegafur | 2010 |
Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Remission Induction; Uterine Cervical Neoplasms | 2002 |
[Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Pyridines; Radiotherapy Dosage; Tegafur | 2005 |
[Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy; Survival Rate; Treatment Outcome | 2006 |
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2006 |
[Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck].
Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Quality of Life; Taxoids | 2007 |
Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Organoplatinum Compounds; Survival Rate | 2007 |
Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Treatment Outcome | 2007 |
[Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Organoplatinum Compounds | 1998 |
[Effect of combination chemotherapy with nedaplatin and 5-FU for head and neck squamous cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds | 2001 |
[Ototoxicity of cis-diammine glycolato platinum, 254-S].
Topics: Aged; Antineoplastic Agents; Audiometry; Cisplatin; Drug Evaluation; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Hearing; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1992 |
[A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Organoplatinum Compounds | 1992 |
[An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Topics: Adenocarcinoma; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Organoplatinum Compounds; Thrombocytopenia | 1992 |
17 other study(ies) available for nedaplatin and Cancer of Head
| Article | Year |
|---|---|
Survey of the Time-Onset Profiles of Nedaplatin-Induced Adverse Events in Head and Neck Cancer Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Head and Neck Neoplasms; Humans; Japan; Organoplatinum Compounds | 2021 |
Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Oxonic Acid; Pharyngeal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2019 |
Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Postoperative Period; Radiotherapy, Adjuvant; Survival Analysis | 2013 |
Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2015 |
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Endoscopy; Ethmoid Sinus; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
[Determination of the Appropriate Timing of Aprepitant Administration for Nausea in Patients with Head and Neck Cancer Receiving Combination Chemotherapy with Docetaxel, Nedaplatin（Divided Doses for 5 Days), and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Morpholines; Nausea; Organoplatinum Compounds; Taxoids; Time Factors | 2015 |
Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Logistic Models; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Risk Factors | 2017 |
[Chemotherapy with MTX, 5-FU and CDGP for treatment of newly diagnosed head and neck cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds | 2009 |
[Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Fatal Outcome; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2010 |
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Radiotherapy; Survival Rate; Tegafur; Treatment Outcome | 2011 |
Digestive symptoms as side effects of combination chemotherapy of docetaxel, nedaplatin and 5-fluorouracil for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Neoplasm Grading; Organoplatinum Compounds; Retrospective Studies; Taxoids | 2012 |
[Combined MTX.5-FU.CDGP for the treatment of head and neck cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Organoplatinum Compounds; Radiography; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis | 2003 |
[Nedaplatin for recurrent cancer of the head and neck].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Tegafur; Uracil | 2004 |
[A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Organoplatinum Compounds | 2005 |
[Combination therapy with TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Oxonic Acid; Pyridines; Taxoids; Tegafur | 2005 |
[Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds | 1998 |
[Experimental study on the anti-tumor effects of CDDP derivatives on head and neck squamous cell carcinoma cell lines].
Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Mice; Mice, Nude; Organoplatinum Compounds | 1988 |